FCB-Pharmicell is building a manufacturing and quality control system for superior cell supply and the most advanced asepsis facility
FCB-Pharmicell began research in this field in the early 90s when terms on stem cell were still unfamiliar to the general public. In the mean time, our accumulated manufacturing technique of stem cell therapeutics and quality inspection standards are close to the commercialization stage. In addition, with possession of advanced cell treatment and storage facilities, we are able to treat the entire process from basic to clinical trials using stem cells. Further, we expect to provide the best consignment services for our clients with extensive experience in stem cell treatment technology as basis.
For all inquiries regarding stem cell research, please contact the number below.
FCB-Pharmicell Cell Treatment
Research Institute
Chief Researcher Yong Man Kim
+82.31.777.9340 Extension 103
E-mail : kimy@fcbpharmicell.com
FCB-Pharmicell Co.,Ltd. 920 Sicox Tower 513-14, Sangdaewon1-dong, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea ¤ýT.82.31.777.9340 ¤ýF. 82.31.777.9343
COPYRIGHT(C) 2007 FCB-PHAMICELL CO.,Ltd. ALL RIGHTS RESERVED.
